Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Predictors of religious participation of older Europeans in good and poor health.

Sowa A, Golinowska S, Deeg D, Principi A, Casanova G, Schulmann K, Ilinca S, Rodrigues R, Moreira A, Gelenkamp H.

Eur J Ageing. 2016;13:145-157. Epub 2016 Mar 12.

2.

Do predictors of volunteering in older age differ by health status?

Principi A, Galenkamp H, Papa R, Socci M, Suanet B, Schmidt A, Schulmann K, Golinowska S, Sowa A, Moreira A, Deeg DJH.

Eur J Ageing. 2016 May 13;13(2):91-102. doi: 10.1007/s10433-016-0377-0. eCollection 2016 Jun.

3.

Fit for caring: factors associated with informal care provision by older caregivers with and without multimorbidity.

Schmidt AE, Ilinca S, Schulmann K, Rodrigues R, Principi A, Barbabella F, Sowa A, Golinowska S, Deeg D, Galenkamp H.

Eur J Ageing. 2016 Apr 23;13(2):103-113. doi: 10.1007/s10433-016-0373-4. eCollection 2016 Jun.

4.

Prognostic value of microsatellite instability and p53 expression in metastatic colorectal cancer treated with oxaliplatin and fluoropyrimidine-based chemotherapy.

Nöpel-Dünnebacke S, Schulmann K, Reinacher-Schick A, Porschen R, Schmiegel W, Tannapfel A, Graeven U.

Z Gastroenterol. 2014 Dec;52(12):1394-401. doi: 10.1055/s-0034-1366781. Epub 2014 Dec 4.

PMID:
25474278
5.

[S3-guideline colorectal cancer version 1.0].

Pox C, Aretz S, Bischoff SC, Graeven U, Hass M, Heußner P, Hohenberger W, Holstege A, Hübner J, Kolligs F, Kreis M, Lux P, Ockenga J, Porschen R, Post S, Rahner N, Reinacher-Schick A, Riemann JF, Sauer R, Sieg A, Scheppach W, Schmitt W, Schmoll HJ, Schulmann K, Tannapfel A, Schmiegel W; Leitlinienprogramm Onkologie der AWMF; Deutschen Krebsgesellschaft e. V; Deutschen Krebshilfe e. V.

Z Gastroenterol. 2013 Aug;51(8):753-854. doi: 10.1055/s-0033-1350264. Epub 2013 Aug 16. German. No abstract available.

6.

Paraneoplastic acanthosis nigricans with cutaneous and mucosal papillomatosis preceding recurrence of a gastric adenocarcinoma.

Schulmann K, Strate K, Pox CP, Wieland U, Kreuter A.

J Clin Oncol. 2012 Nov 10;30(32):e325-6. doi: 10.1200/JCO.2012.42.5454. Epub 2012 Sep 24. No abstract available.

PMID:
23008315
7.

Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group.

Reinacher-Schick A, Schulmann K, Modest DP, Bruns N, Graeven U, Jaworska M, Greil R, Porschen R, Arnold D, Schmiegel W, Tannapfel A.

BMC Cancer. 2012 Aug 9;12:349. doi: 10.1186/1471-2407-12-349.

8.

TFAP2E-DKK4 and chemoresistance in colorectal cancer.

Ebert MP, Tänzer M, Balluff B, Burgermeister E, Kretzschmar AK, Hughes DJ, Tetzner R, Lofton-Day C, Rosenberg R, Reinacher-Schick AC, Schulmann K, Tannapfel A, Hofheinz R, Röcken C, Keller G, Langer R, Specht K, Porschen R, Stöhlmacher-Williams J, Schuster T, Ströbel P, Schmid RM.

N Engl J Med. 2012 Jan 5;366(1):44-53. doi: 10.1056/NEJMoa1009473.

9.

Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome.

Morak M, Koehler U, Schackert HK, Steinke V, Royer-Pokora B, Schulmann K, Kloor M, Höchter W, Weingart J, Keiling C, Massdorf T, Holinski-Feder E; German HNPCC consortium.

J Med Genet. 2011 Aug;48(8):513-9. doi: 10.1136/jmedgenet-2011-100050. Epub 2011 Jun 28.

PMID:
21712435
10.

Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group.

Baraniskin A, Munding J, Schulmann K, Meier D, Porschen R, Arkenau HT, Graeven U, Schmiegel W, Tannapfel A, Reinacher-Schick A.

Clin Colorectal Cancer. 2011 Mar 1;10(1):24-9. doi: 10.3816/CCC.2011.n.003.

PMID:
21609932
11.

Psychological impact of genetic counseling for hereditary nonpolyposis colorectal cancer: the role of cancer history, gender, age, and psychological distress.

Hasenbring MI, Kreddig N, Deges G, Epplen JT, Kunstmann E, Stemmler S, Schulmann K, Willert J, Schmiegel W.

Genet Test Mol Biomarkers. 2011 Apr;15(4):219-25. doi: 10.1089/gtmb.2010.0165. Epub 2010 Dec 31.

PMID:
21194311
12.

Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility.

Lascorz J, Försti A, Chen B, Buch S, Steinke V, Rahner N, Holinski-Feder E, Morak M, Schackert HK, Görgens H, Schulmann K, Goecke T, Kloor M, Engel C, Büttner R, Kunkel N, Weires M, Hoffmeister M, Pardini B, Naccarati A, Vodickova L, Novotny J, Schreiber S, Krawczak M, Bröring CD, Völzke H, Schafmayer C, Vodicka P, Chang-Claude J, Brenner H, Burwinkel B, Propping P, Hampe J, Hemminki K.

Carcinogenesis. 2010 Sep;31(9):1612-9. doi: 10.1093/carcin/bgq146. Epub 2010 Jul 7.

PMID:
20610541
13.

Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.

Engel C, Rahner N, Schulmann K, Holinski-Feder E, Goecke TO, Schackert HK, Kloor M, Steinke V, Vogelsang H, Möslein G, Görgens H, Dechant S, von Knebel Doeberitz M, Rüschoff J, Friedrichs N, Büttner R, Loeffler M, Propping P, Schmiegel W; German HNPCC Consortium.

Clin Gastroenterol Hepatol. 2010 Feb;8(2):174-82. doi: 10.1016/j.cgh.2009.10.003. Epub 2009 Oct 14.

PMID:
19835992
14.

Truncating mutations in Peutz-Jeghers syndrome are associated with more polyps, surgical interventions and cancers.

Salloch H, Reinacher-Schick A, Schulmann K, Pox C, Willert J, Tannapfel A, Heringlake S, Goecke TO, Aretz S, Stemmler S, Schmiegel W.

Int J Colorectal Dis. 2010 Jan;25(1):97-107. doi: 10.1007/s00384-009-0793-0. Epub 2009 Sep 2.

PMID:
19727776
15.

Antitumor activity of the HER2 dimerization inhibitor pertuzumab on human colon cancer cells in vitro and in vivo.

Pohl M, Stricker I, Schoeneck A, Schulmann K, Klein-Scory S, Schwarte-Waldhoff I, Hasmann M, Tannapfel A, Schmiegel W, Reinacher-Schick A.

J Cancer Res Clin Oncol. 2009 Oct;135(10):1377-86. doi: 10.1007/s00432-009-0579-3. Epub 2009 Apr 2.

PMID:
19340455
16.

Small bowel cancer risk in Lynch syndrome.

Schulmann K, Engel C, Propping P, Schmiegel W.

Gut. 2008 Nov;57(11):1629-30. No abstract available.

PMID:
18941010
17.

Ten recently identified associations between nsSNPs and colorectal cancer could not be replicated in German families.

Frank B, Burwinkel B, Bermejo JL, Försti A, Hemminki K, Houlston R, Mangold E, Rahner N, Friedl W, Friedrichs N, Buettner R, Engel C, Loeffler M, Holinski-Feder E, Morak M, Keller G, Schackert HK, Krüger S, Goecke T, Moeslein G, Kloor M, Gebert J, Kunstmann E, Schulmann K, Rüschoff J, Propping P; German HNPCC Consortium.

Cancer Lett. 2008 Nov 18;271(1):153-7. doi: 10.1016/j.canlet.2008.05.043. Epub 2008 Jul 10.

PMID:
18619730
18.

Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group.

Müller CI, Schulmann K, Reinacher-Schick A, Andre N, Arnold D, Tannapfel A, Arkenau H, Hahn SA, Schmoll SH, Porschen R, Schmiegel W, Graeven U; AIO Colorectal Study Group.

Int J Colorectal Dis. 2008 Nov;23(11):1033-9. doi: 10.1007/s00384-008-0504-2. Epub 2008 Jul 2.

PMID:
18594845
19.

Beyond Field Effect: Analysis of Shrunken Centroids in Normal Esophageal Epithelia Detects Concomitant Esophageal Adenocarcinoma.

Selaru FM, Wang S, Yin J, Schulmann K, Xu Y, Mori Y, Olaru AV, Sato F, Hamilton JP, Abraham JM, Schneider P, Greenwald BD, Brabender J, Meltzer SJ.

Bioinform Biol Insights. 2007;1:127-136.

20.

Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features.

Sato F, Jin Z, Schulmann K, Wang J, Greenwald BD, Ito T, Kan T, Hamilton JP, Yang J, Paun B, David S, Olaru A, Cheng Y, Mori Y, Abraham JM, Yfantis HG, Wu TT, Fredericksen MB, Wang KK, Canto M, Romero Y, Feng Z, Meltzer SJ.

PLoS One. 2008 Apr 2;3(4):e1890. doi: 10.1371/journal.pone.0001890.

21.

Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC.

Morak M, Schackert HK, Rahner N, Betz B, Ebert M, Walldorf C, Royer-Pokora B, Schulmann K, von Knebel-Doeberitz M, Dietmaier W, Keller G, Kerker B, Leitner G, Holinski-Feder E.

Eur J Hum Genet. 2008 Jul;16(7):804-11. doi: 10.1038/ejhg.2008.25. Epub 2008 Feb 27.

22.

The patient with multiple intestinal polyps.

Schulmann K, Pox C, Tannapfel A, Schmiegel W.

Best Pract Res Clin Gastroenterol. 2007;21(3):409-26.

PMID:
17544108
23.

Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium.

Goecke T, Schulmann K, Engel C, Holinski-Feder E, Pagenstecher C, Schackert HK, Kloor M, Kunstmann E, Vogelsang H, Keller G, Dietmaier W, Mangold E, Friedrichs N, Propping P, Krüger S, Gebert J, Schmiegel W, Rueschoff J, Loeffler M, Moeslein G; German HNPCC Consortium.

J Clin Oncol. 2006 Sep 10;24(26):4285-92. Epub 2006 Aug 14.

PMID:
16908935
24.

Mutational and LOH analyses of the chromosome 4q region in esophageal adenocarcinoma.

Sterian A, Kan T, Berki AT, Mori Y, Olaru A, Schulmann K, Sato F, Wang S, Paun B, Cai K, Hamilton JP, Abraham JM, Meltzer SJ.

Oncology. 2006;70(3):168-72. Epub 2006 Jul 7.

PMID:
16837775
25.

Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis.

Wang S, Zhan M, Yin J, Abraham JM, Mori Y, Sato F, Xu Y, Olaru A, Berki AT, Li H, Schulmann K, Kan T, Hamilton JP, Paun B, Yu MM, Jin Z, Cheng Y, Ito T, Mantzur C, Greenwald BD, Meltzer SJ.

Oncogene. 2006 Jun 1;25(23):3346-56. Epub 2006 Jan 30.

PMID:
16449976
26.

The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC).

Krüger S, Bier A, Engel C, Mangold E, Pagenstecher C, von Knebel Doeberitz M, Holinski-Feder E, Moeslein G, Schulmann K, Plaschke J, Rüschoff J, Schackert HK; German Hereditary Non-Polyposis Colorectal Cancer Consortium.

J Med Genet. 2005 Oct;42(10):769-73.

27.

Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability.

Schulmann K, Mori Y, Croog V, Yin J, Olaru A, Sterian A, Sato F, Wang S, Xu Y, Deacu E, Berki AT, Hamilton JP, Kan T, Abraham JM, Schmiegel W, Harpaz N, Meltzer SJ.

Gastroenterology. 2005 Jul;129(1):74-85.

PMID:
16012936
28.

Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer.

Mangold E, Pagenstecher C, Friedl W, Mathiak M, Buettner R, Engel C, Loeffler M, Holinski-Feder E, Müller-Koch Y, Keller G, Schackert HK, Krüger S, Goecke T, Moeslein G, Kloor M, Gebert J, Kunstmann E, Schulmann K, Rüschoff J, Propping P.

Int J Cancer. 2005 Sep 20;116(5):692-702.

29.

Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.

Schulmann K, Sterian A, Berki A, Yin J, Sato F, Xu Y, Olaru A, Wang S, Mori Y, Deacu E, Hamilton J, Kan T, Krasna MJ, Beer DG, Pepe MS, Abraham JM, Feng Z, Schmiegel W, Greenwald BD, Meltzer SJ.

Oncogene. 2005 Jun 9;24(25):4138-48.

PMID:
15824739
30.

HNPCC-associated small bowel cancer: clinical and molecular characteristics.

Schulmann K, Brasch FE, Kunstmann E, Engel C, Pagenstecher C, Vogelsang H, Krüger S, Vogel T, Knaebel HP, Rüschoff J, Hahn SA, Knebel-Doeberitz MV, Moeslein G, Meltzer SJ, Schackert HK, Tympner C, Mangold E, Schmiegel W; German HNPCC Consortium.

Gastroenterology. 2005 Mar;128(3):590-9.

PMID:
15765394
31.

Feasibility and diagnostic utility of video capsule endoscopy for the detection of small bowel polyps in patients with hereditary polyposis syndromes.

Schulmann K, Hollerbach S, Kraus K, Willert J, Vogel T, Möslein G, Pox C, Reiser M, Reinacher-Schick A, Schmiegel W.

Am J Gastroenterol. 2005 Jan;100(1):27-37.

PMID:
15654777
32.

Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.

Deacu E, Mori Y, Sato F, Yin J, Olaru A, Sterian A, Xu Y, Wang S, Schulmann K, Berki A, Kan T, Abraham JM, Meltzer SJ.

Cancer Res. 2004 Nov 1;64(21):7690-6.

33.

Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.

Plaschke J, Engel C, Krüger S, Holinski-Feder E, Pagenstecher C, Mangold E, Moeslein G, Schulmann K, Gebert J, von Knebel Doeberitz M, Rüschoff J, Loeffler M, Schackert HK.

J Clin Oncol. 2004 Nov 15;22(22):4486-94. Epub 2004 Oct 13.

PMID:
15483016
34.

Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.

Aretz S, Uhlhaas S, Sun Y, Pagenstecher C, Mangold E, Caspari R, Möslein G, Schulmann K, Propping P, Friedl W.

Hum Mutat. 2004 Nov;24(5):370-80.

PMID:
15459959
35.

Impact of genetic counseling and testing on colorectal cancer screening behavior.

Kunstmann E, Generalow A, Epplen JT, Schulmann K.

Genet Test. 2004 Summer;8(2):79. No abstract available.

PMID:
15345101
36.

HNPCC: six new pathogenic mutations.

Kunstmann E, Vieland J, Brasch FE, Hahn SA, Epplen JT, Schulmann K, Schmiegel W.

BMC Med Genet. 2004 Jun 24;5:16.

37.

[Diagnostic utility of capsule endoscopy in occult gastrointestinal bleeding].

Kraus K, Hollerbach S, Pox C, Willert J, Schulmann K, Schmiegel W.

Dtsch Med Wochenschr. 2004 Jun 11;129(24):1369-74. German.

PMID:
15188089
38.

Prevalence of familial pancreatic cancer in Germany.

Bartsch DK, Kress R, Sina-Frey M, Grützmann R, Gerdes B, Pilarsky C, Heise JW, Schulte KM, Colombo-Benkmann M, Schleicher C, Witzigmann H, Pridöhl O, Ghadimi MB, Horstmann O, von Bernstorff W, Jochimsen L, Schmidt J, Eisold S, Estévéz-Schwarz L, Hahn SA, Schulmann K, Böck W, Gress TM, Zügel N, Breitschaft K, Prenzel K, Messmann H, Endlicher E, Schneider M, Ziegler A, Schmiegel W, Schäfer H, Rothmund M, Rieder H.

Int J Cancer. 2004 Jul 20;110(6):902-6.

39.

Capsule endoscopy for small bowel surveillance in hereditary intestinal polyposis and non-polyposis syndromes.

Schulmann K, Schmiegel W.

Gastrointest Endosc Clin N Am. 2004 Jan;14(1):149-58. Review. No abstract available.

PMID:
15062388
40.

Identification of genes uniquely involved in frequent microsatellite instability colon carcinogenesis by expression profiling combined with epigenetic scanning.

Mori Y, Yin J, Sato F, Sterian A, Simms LA, Selaru FM, Schulmann K, Xu Y, Olaru A, Wang S, Deacu E, Abraham JM, Young J, Leggett BA, Meltzer SJ.

Cancer Res. 2004 Apr 1;64(7):2434-8.

41.

Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue.

Plaschke J, Krüger S, Dietmaier W, Gebert J, Sutter C, Mangold E, Pagenstecher C, Holinski-Feder E, Schulmann K, Möslein G, Rüschoff J, Engel C, Evans G, Schackert HK; German HNPCC Consortium.

Hum Mutat. 2004 Mar;23(3):285.

PMID:
14974087
42.

[How does this work? Capsule endoscopy].

Schulmann K, Schmiegel W.

MMW Fortschr Med. 2003 Sep 4;145(35-36):58-9. German. No abstract available.

PMID:
14584219
43.

Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.

Schulmann K, Hahn SA, Brasch F, Schmiegel W.

Cancer. 2003 Oct 15;98(8):1774-5; author reply 1775-6. No abstract available.

44.

Diagnosing small bowel Crohn's disease with wireless capsule endoscopy.

Schulmann K, Hollerbach S, Schmiegel W.

Gut. 2003 Oct;52(10):1531-2; author reply 1532. No abstract available.

45.

[Conventional and molecular screening (fecal tests)].

Pox C, Schulmann K, Schmiegel W.

Internist (Berl). 2003 Mar;44(3):287-93. German. No abstract available.

PMID:
12731415
46.

Endoscopically assisted video capsule endoscopy of the small bowel in patients with functional gastric outlet obstruction.

Hollerbach S, Kraus K, Willert J, Schulmann K, Schmiegel W.

Endoscopy. 2003 Mar;35(3):226-9.

PMID:
12584642
47.

Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers.

Friedl W, Uhlhaas S, Schulmann K, Stolte M, Loff S, Back W, Mangold E, Stern M, Knaebel HP, Sutter C, Weber RG, Pistorius S, Burger B, Propping P.

Hum Genet. 2002 Jul;111(1):108-11. Epub 2002 Jun 13.

PMID:
12136244
48.

Colonic cancer and polyps.

Schulmann K, Reiser M, Schmiegel W.

Best Pract Res Clin Gastroenterol. 2002 Feb;16(1):91-114. Review.

PMID:
11977931
49.

Enrichment of mutant KRAS alleles in pancreatic juice by subtractive iterative polymerase chain reaction.

Fischer C, Büthe J, Nollau P, Hollerbach S, Schulmann K, Schmiegel W, Wagener C, Tschentscher P.

Lab Invest. 2001 Jun;81(6):827-31.

PMID:
11406644
50.

[Regression grading of neoadjuvant non-small-cell lung carcinoma treatment].

Junker K, Thomas M, Schulmann K, Klinke V, Bosse U, Müller KM.

Pathologe. 1997 Mar;18(2):131-40. German.

PMID:
9244871

Supplemental Content

Loading ...
Support Center